THERANOSTICS 2016* , ,
Presentations this author is a contributor to:
Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T (#33)
4:06 PM
Harshad R Kulkarni
Improving Patient Outcomes with PSMA Theranostics